Profound Medical (TSE:PRN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Profound Medical Corp. has successfully closed a $40.25 million public offering of common shares, with the funds aimed at boosting the commercialization of their TULSA-PRO and Sonalleve systems. The offering saw strong interest with the full exercise of the over-allotment option, highlighting investor confidence in Profound Medical’s innovative medical device technologies.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.